Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sarilumab with or without Azithromycin and Hydroxychloroquine in COVID-19
NCT04341870Phase 3Suspended
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Apr 2020
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of azithromycin, hydroxychloroquine in coronavirus disease 2019 (COVID-19), sponsored by Assistance publique - Hôpitaux de Paris. Started Apr 2020; status: suspended.
02
Drugs
azithromycinhydroxychloroquine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04341870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04341870.